Human leukocyte extract enhances albendazole efficacy against Echinococcus multilocularis in mice by reducing parasitic microRNAs, myeloid and lymphoid immunosuppressive cells. [PDF]
Hrčková G +6 more
europepmc +1 more source
Triclabendazole disrupts mitochondrial electron transport <i>in vitro</i>. [PDF]
Kämpfer T +7 more
europepmc +1 more source
Phytochemical Profiling, Antioxidant, Cytotoxicity, and Anthelmintic Activity of the Bark Extracts of <i>Terminalia superba</i> Against the Murine Intestinal Nematode <i>Heligmosomoides polygyrus</i>: An Integrated In Vitro and In Silico Approach. [PDF]
Nganji Nsa B +11 more
europepmc +1 more source
Assessing the efficacy of high-dose rifampicin plus albendazole against onchocerciasis. [PDF]
Ahiadorme M +27 more
europepmc +1 more source
Severe adverse reaction induced by albendazole and praziquantel for cystic echinococcosis. [PDF]
Zhao L, Xie W, Li P.
europepmc +1 more source
An Integrated Approach of Proteomic, Cheminformatic, and In Vitro Drug Screening to Identify Potential Therapeutic Targets of <i>Taenia solium</i> Cysticerci Proteases. [PDF]
Kaur R +9 more
europepmc +1 more source
Use of albendazole sulfoxide, albendazole sulfone, and combined solutions as scolicidal agents on hydatid cysts (in vitro study). [PDF]
Adas G +5 more
europepmc +1 more source
Pharmacokinetic barriers to oxfendazole flukicidal efficacy. [PDF]
Ceballos L +5 more
europepmc +1 more source
Triclabendazole and Other Fasciolicides: Resistance of <i>Fasciola hepatica</i> in Ruminants. [PDF]
Hou M +7 more
europepmc +1 more source
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteers. [PDF]
Jongo S +17 more
europepmc +1 more source

